This is a GSA Schedule solicitation for reference laboratory services to provide medical laboratory testing for diagnosis, prevention, treatment, and health assessment. The performance location is domestic, defined as the 48 contiguous states, Alaska, Hawaii, Puerto Rico, Washington, D.C., and U.S. territories, though offerors may propose service for individual states or nationwide and must comply with all state-specific licensing requirements. The contract will be for new items only, with no grey market or refurbished goods, and all reagents must be FDA-cleared or identified as Laboratory Developed Tests. Offerors must categorize their services under predefined Special Item Numbers (SINs) and tests must have CPT codes, with no home diagnostic test kits allowed under this schedule. The government will award indefinite-delivery, indefinite-quantity contracts that eligible users may use on a nonmandatory basis.

This solicitation seeks to establish non-mandatory Federal Supply Schedule contracts for clinical reference laboratory testing services to support patient diagnosis and care. The performance location is domestic, defined as the 48 contiguous states, Alaska, Hawaii, Puerto Rico, Washington, D.C., and U.S. territories, though offerors must meet strict state licensing requirements and can propose service for individual states or nationwide. Offerors must provide new items only, with all testing categorized under predefined Special Item Numbers (SINs), using FDA-cleared reagents or approved Laboratory Developed Tests, and associated with current CPT codes. The contractor is responsible for delivery to destinations within the 48 contiguous states and D.C., with optional pricing for other domestic areas, and must meet specified delivery timelines after order receipt. Compliance with all state and federal licensing, including specific out-of-state permits for certain states, is mandatory, and subcontracting cannot be used to circumvent these requirements.

This is a GSA Schedule solicitation for reference laboratory services to provide medical laboratory testing for diagnosis, prevention, treatment, and patient health assessment. The performance location is domestic, defined as the 48 contiguous states, Alaska, Hawaii, Puerto Rico, Washington, D.C., and U.S. territories, though offerors can propose service for individual states or nationwide and must comply with all state licensing requirements. The contract will be for new items only, with no grey market or refurbished goods, and all reagents must be FDA-cleared or identified as Laboratory Developed Tests. Offerors must categorize their diagnostic testing services under predefined Special Item Numbers (SINs) using CPT codes, and home diagnostic tests are excluded from this schedule.

This is a GSA Schedule solicitation for reference laboratory services to provide medical laboratory testing for diagnosis, prevention, treatment, and health assessment. The performance location is domestic, defined as the 48 contiguous states, Alaska, Hawaii, Puerto Rico, Washington, D.C., and U.S. territories, though offerors may be limited to specific geographic service areas based on licensing. Offerors must provide services in at least one state, comply with all state and federal licensing and accreditation requirements—including specific out-of-state permits for certain states—and cannot subcontract to circumvent these rules. All tests must be categorized under predefined Special Item Numbers (SINs), have CPT codes, and use FDA-cleared reagents or be classified as Laboratory Developed Tests (LDTs). The solicitation is for new items only, and the Trade Agreements Act applies, restricting services to U.S.-made or designated country end products.